Clinical Trial Update: PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease [NA]

View source ↗

Summary

A completed clinical trial update suggests that polycystic ovary syndrome may be a risk factor for developing non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Polycystic Ovary Syndrome

Snippet

Sponsor: Ziekenhuis Oost-Limburg | Conditions: NAFLD (Nonalcoholic Fatty Liver Disease), Polycystic Ovarian Syndrome (PCOS) | NA | Status: COMPLETED